pharma news today obesity drugs glp-1 september 2025 FDA takes aim at telehealth companies for promoting unofficial weight loss drug dupes The world is desperate for

People want to know whether Gala GLP-1 actually works, how safe it is, and what the experience feels like over time

We also provide itemized receipts in case you need to self-submit to your benefits provider

Purpose-built for physicians Q&A: Liraglutide outperforms colesevelam in reducing stool frequency in bile acid diarrhea Liraglutide reduced stool frequency in a small subset of patients with bile acid diarrhea and warrants consideration as a potential new treatment modality, according to research in The Lancet Gastroenterology and Hepatology

It's taking an increasingly long time

The journey to muscle growth and overall health is a marathon, not a sprint